10 Stocks Hit Strong Buy Signals with High Confidence — September 2026
Explore 10 stocks identified by OpportunityRadar with scores up to 68, including two 'STRONG BUY' signals at 100% confidence and impressive 3-month returns.
by Kowsalya
Published Sep 08, 2026 | Updated Sep 08, 2026 | 📖 10 min read
OpportunityRadar Uncovers 10 Promising Buy Signals for September 2026
As September 2026 unfolds, the OpportunityRadar scanner has flagged a compelling list of stocks exhibiting robust technical and fundamental indicators. Leading the pack are Zymeworks Inc. (ZYME) and GitLab Inc. (GTLB), both registering an impressive OpportunityRadar Score of 68. These two tickers stand out with 'STRONG BUY' signals, each backed by a perfect 100% confidence rating and a 'STRONG ENTRY' recommendation. Notably, GTLB has demonstrated significant price appreciation, posting a 56.8% return over the last three months, while ZYME also delivered solid returns of 18.34% in one month and 22.91% over three months.
The broader scan reveals a landscape dominated by 'BUY' and 'STRONG BUY' signals across the top 10 tickers. Seven of these ten candidates boast a 100% confidence rating, indicating strong alignment across underlying confirmation factors. The average Relative Strength Index (RSI) for this group sits around 55.7, suggesting most are in neutral territory, with five exhibiting a bullish MACD crossover and five showing a bearish MACD, highlighting a mixed technical picture even among high-scoring opportunities.
Top 10 Signals at a Glance
| # | Ticker | Company | Price | Score | Confidence | RSI | MACD | 1-Month |
|---|---|---|---|---|---|---|---|---|
| 1 | ZYME | Zymeworks Inc. | $28.59 | 68 | 100% | 56.4 | BULL | 18.34% |
| 2 | GTLB | GitLab Inc. | $47.51 | 68 | 100% | 64.5 | BULL | 16.65% |
| 3 | CAH | Cardinal Health, Inc. | $241.38 | 66 | 100% | 56.0 | BULL | 1.77% |
| 4 | SSNC | SS&C Technologies Holdings, In | $80.71 | 65 | 83% | 50.7 | BEAR | 1.18% |
| 5 | HPQ | HP Inc. | $31.0 | 65 | 100% | 56.5 | BULL | 4.03% |
| 6 | SCSC | ScanSource, Inc. | $57.8 | 65 | 100% | 58.0 | BULL | 7.06% |
| 7 | A | Agilent Technologies, Inc. | $147.34 | 65 | 83% | 47.3 | BEAR | -0.93% |
| 8 | ESTC | Elastic N.V. | $90.32 | 64 | 67% | 58.2 | BEAR | 18.34% |
| 9 | YEXT | Yext, Inc. | $6.34 | 64 | 67% | 54.8 | BEAR | 9.98% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc | $810.05 | 64 | 67% | 54.4 | BEAR | 0.25% |
#1: ZYME — Zymeworks Inc.
Zymeworks Inc. (ZYME) emerges with a 'STRONG BUY' signal, underpinned by an OpportunityRadar Score of 68. The signal is reinforced by a 100% confidence rating and a 'STRONG ENTRY' recommendation, reflecting a high conviction from the scanner. Technical indicators show an RSI of 56.4, placing it in neutral territory, while the MACD is in a BULLish state. Its technical score is 76, significantly higher than its fundamental score of 56. Performance over the past month shows an 18.34% return, extending to a 22.91% gain over three months, indicating recent positive momentum.
Despite the strong signal and high confidence, the Risk/Reward ratio for ZYME stands at 1.0. While this indicates an equal potential for risk and reward based on the scanner's parameters, it doesn't offer the more favorable ratios seen in other high-scoring stocks. Investors should note the absence of explicit stop levels or price targets in the current data, necessitating further individual analysis for risk management.
#2: GTLB — GitLab Inc.
GitLab Inc. (GTLB) shares the top spot with ZYME, also boasting an OpportunityRadar Score of 68 and a 'STRONG BUY' signal with 100% confidence and a 'STRONG ENTRY'. Its technical score of 76 mirrors ZYME, while its fundamental score is 56. The stock's RSI is at 64.5, approaching the upper bound of neutral territory, and its MACD is firmly in a BULLish configuration. GTLB has delivered impressive returns, with a 16.65% gain in the last month and a robust 56.8% surge over the past three months, signaling strong upward momentum.
A notable aspect of GTLB is its Risk/Reward ratio of 1.7, which suggests a more favorable balance of potential upside relative to downside risk compared to ZYME. However, with the RSI at 64.5, it is closer to the commonly perceived overbought threshold of 70, which could warrant monitoring for potential short-term pullbacks, although it is not yet in overbought territory.
#3: CAH — Cardinal Health, Inc.
Cardinal Health, Inc. (CAH) earns a 'BUY' signal with an OpportunityRadar Score of 66. The scanner assigns a 100% confidence rating and a 'STRONG ENTRY' recommendation, underscoring conviction in this opportunity. CAH exhibits a balanced technical and fundamental profile, with a technical score of 71 and a fundamental score of 58. Its RSI is 56.0, situated comfortably in the middle of the neutral range, complemented by a BULLish MACD. The stock has posted a 1.77% return over the last month and a 13.5% gain over the past three months.
The Risk/Reward ratio for CAH, similar to ZYME, is 1.0. While this indicates an even risk-reward profile, the more modest 1-month return of 1.77% compared to other 100% confidence signals like ZYME (18.34%) and GTLB (16.65%) suggests that its recent short-term momentum is less pronounced, which could be a factor for consideration for those prioritizing immediate gains.
#4: SSNC — SS&C Technologies Holdings, In
SS&C Technologies Holdings, Inc. (SSNC) shows an OpportunityRadar Score of 65 and a 'BUY' signal. The confidence level is 83%, with a 'STRONG ENTRY' recommendation. Its technical score is 70, and its fundamental score is 58. The RSI for SSNC is 50.7, indicating a very neutral position. However, the MACD is currently in a BEARish state, presenting a divergence from the 'BUY' signal. The stock's recent performance includes a 1.18% return over the last month and a 17.5% gain over three months.
The primary risk factor for SSNC lies in its MACD BEAR signal, which directly contradicts the 'BUY' signal and 83% confidence. This technical divergence suggests that while other factors may be positive, the short-term momentum, as indicated by MACD, is currently trending downwards, warranting careful observation for confirmation of a potential reversal or continued weakness.
#5: HPQ — HP Inc.
HP Inc. (HPQ) registers an OpportunityRadar Score of 65, accompanied by a 'BUY' signal and a robust 100% confidence rating, along with a 'STRONG ENTRY'. The technical score stands at 69, while the fundamental score is 58. HPQ's RSI is 56.5, indicating a healthy neutral position, and its MACD is in a BULLish configuration. The stock has delivered a 4.03% return in the last month and a solid 24.3% return over the past three months, demonstrating consistent upward movement.
A significant point of caution for HPQ is its Risk/Reward ratio of 0.6. This low ratio suggests that the potential reward might not adequately compensate for the inherent risk, according to the scanner's assessment. Investors typically seek higher Risk/Reward ratios to ensure that potential gains outweigh potential losses, making this a critical factor to evaluate despite the strong confidence rating.
#6: SCSC — ScanSource, Inc.
ScanSource, Inc. (SCSC) is identified with an OpportunityRadar Score of 65, receiving a 'BUY' signal and a 100% confidence rating with a 'STRONG ENTRY'. The technical component of its score is 73, indicating strong technical health, though its fundamental score is 53, the lowest among the top 10. The RSI is 58.0, in a neutral-to-strong position, and the MACD shows a BULLish trend. SCSC has seen a 7.06% return over the last month and an 18.27% gain over three months.
The main area of concern for SCSC is its relatively lower fundamental score of 53 compared to its peers in this list. While technical strength is evident, a weaker fundamental profile could indicate underlying issues that might impact long-term stability or growth potential. The Risk/Reward ratio of 1.6 is favorable, but the fundamental foundation should be considered.
#7: A — Agilent Technologies, Inc.
Agilent Technologies, Inc. (A) has an OpportunityRadar Score of 65 and a 'BUY' signal, with an 83% confidence rating and a 'STRONG ENTRY'. Its technical score is 70, and fundamental score is 58. The RSI for Agilent Technologies is 47.3, indicating it is leaning towards oversold territory, though still within a neutral range. The MACD, however, is in a BEARish state, similar to SSNC. Over the past month, the stock has experienced a -0.93% return, though it has gained 8.75% over three months.
The negative 1-month return of -0.93% combined with a BEARish MACD signal presents a notable risk for Agilent Technologies. Despite the overall 'BUY' signal and 83% confidence, these short-term indicators suggest recent downward pressure that could persist. The RSI at 47.3 is also on the lower side, indicating a lack of recent buying strength.
#8: ESTC — Elastic N.V.
Elastic N.V. (ESTC) registers an OpportunityRadar Score of 64 and a 'BUY' signal. The confidence rating is 67%, with an 'ENTRY' recommendation. Its technical score is 70, and fundamental score is 56. The RSI is 58.2, within a neutral range, but the MACD is in a BEARish state. ESTC has shown strong performance with an 18.34% return in the last month and an impressive 47.44% gain over three months.
The lower confidence rating of 67% for ESTC, coupled with a BEARish MACD signal, suggests that while the stock has delivered strong recent returns, there might be conflicting signals or fewer confirming factors compared to higher-confidence opportunities. Investors should weigh the strong past performance against the current technical divergence and moderate confidence level.
#9: YEXT — Yext, Inc.
Yext, Inc. (YEXT) also holds an OpportunityRadar Score of 64 and a 'BUY' signal, with a 67% confidence rating and an 'ENTRY' recommendation. Its technical score is 71, and its fundamental score is 53, matching SCSC for the lowest fundamental score in this top 10. The RSI stands at 54.8, indicating neutrality, but the MACD is in a BEARish state. YEXT has achieved a 9.98% return over the last month and a significant 66.27% gain over three months.
Similar to ESTC, YEXT carries a 67% confidence rating and a BEARish MACD, indicating some caution. Furthermore, its fundamental score of 53 is among the lowest in this selection, suggesting that while its technical momentum, particularly over three months, has been strong, the underlying fundamental picture is less robust. The current price of $6.34 also places it in the low-price stock category, which can sometimes imply higher volatility.
#10: REGN — Regeneron Pharmaceuticals, Inc
Regeneron Pharmaceuticals, Inc. (REGN) completes our top 10 list with an OpportunityRadar Score of 64 and a 'BUY' signal. It has a 67% confidence rating and an 'ENTRY' recommendation. The technical score is 70, and the fundamental score is 55. REGN's RSI is 54.4, in a neutral position, but its MACD is in a BEARish state. The stock has seen a modest 0.25% return over the last month but a strong 31.46% gain over three months.
As with ESTC and YEXT, REGN's 67% confidence rating and BEARish MACD signal are points of consideration. While the 3-month return is strong, the very low 1-month return of 0.25% indicates a recent slowdown in momentum. This combination suggests that while there might be long-term potential, short-term trends are currently less favorable, requiring careful monitoring.
Key Observations Across the Scan
- Confidence Levels: Seven out of the ten profiled tickers—ZYME, GTLB, CAH, HPQ, SCSC, WMB, and SLB (from the broader list, but specifically ZYME, GTLB, CAH, HPQ, SCSC within the top 10)—received a 100% confidence rating, highlighting strong conviction from the scanner.
- Signal Strength: Two tickers, ZYME and GTLB, were flagged with 'STRONG BUY' signals, while the remaining eight in the top 10 received 'BUY' signals.
- MACD Divergence: A significant observation is that five of the ten tickers (SSNC, A, ESTC, YEXT, REGN) display a MACD BEAR signal despite receiving overall 'BUY' signals, suggesting a potential conflict in short-term momentum.
- Average RSI: The average RSI across the top 10 tickers is approximately 55.7, indicating that most are in a neutral price momentum zone, not exhibiting extreme overbought or oversold conditions.
- Strong 3-Month Returns: Several tickers demonstrated robust performance over the past three months, with GTLB leading with 56.8%, followed by ESTC at 47.44%, and YEXT at 66.27%.
Key Risk Factors
- MACD Bearish Divergence: Five of the top 10 tickers (SSNC, A, ESTC, YEXT, REGN) show a MACD BEAR signal despite a 'BUY' signal. This divergence suggests that while other factors are positive, the short-term trend as indicated by MACD may be turning negative or already is, which warrants increased scrutiny.
- Low Risk/Reward Ratios: HPQ stands out with a notably low Risk/Reward ratio of 0.6. This indicates that the potential return for HPQ might not be proportionate to the risk involved, a critical factor for investors to consider.
- Weak Recent Performance & Lower Confidence: Agilent Technologies (A) recorded a negative 1-month return of -0.93% and a MACD BEAR signal, despite an 83% confidence. Similarly, ESTC, YEXT, and REGN have lower confidence ratings of 67% combined with MACD BEAR signals, suggesting less robust overall conviction from the scanner.
About Our Methodology
OpportunityRadar scans 6,600+ US stocks daily using 15+ technical indicators including RSI, MACD, Bollinger Bands, ADX, Aroon, support/resistance levels, and volume analysis, combined with fundamental metrics. Stocks are scored 0-100 with signals ranging from Accumulate to Strong Buy. Entry confidence is rated 50-100% based on 6 confirmation factors.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Data as of September 08, 2026.